The weight loss results from the current analyses are similarly aligned with clinical trials, however less pronounced as SURPASS-2 reported a mean weight change from baseline of 7.6 kg, 9.3 kg, and 11.2 kg for tirzepatide doses of 5 mg, 10 mg, and 15 mg, respectively and 5.7 kg with 1 mg semaglutide [21]
The Ca 2+ signaling cascade is further amplified by store-operated calcium entry (SOCE)
It covers why GLP-1 drugs put muscle at risk, what the STEP trial data shows on lean mass changes, and why the scale alone cannot detect this problem.Read Part 1: Semaglutide & Muscle Loss Integrate InBody into your GLP-1 programme today Medical Disclaimer: This article is for informational and educational purposes only and is intended for healthcare professionals
Following this adjustment, the filled random-effects meta-analysis yielded an effect size of 0.36 (95% CI: 3.694.42)
Understanding your GLP-1 medication before you start Before you open a single package, you need to understand what you are working with
Were not offering a quick fix
